Sunday, October 22, 2017 4:02:53 PM
FY2017 Q1: $28,477
FY2017 Q2: $1,542,389
FY2017 Q3: $1,809,064
FY2017 Q4: $3,251,043
FY2017 Total: $6,630,973
FY2018 Q1: $5,900,374
The backbone for this rapid growth is still developing. So expect to see continued increasing revenues going forward for the foreseeable future!
Long AMFE
Rec
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM